Kai Dallmeier - Concepedia

Author

Kai Dallmeier

Rega Institute for Medical Research ORCID

Also Known As

Dallmeier, Kai, K Dallmeier, K. Dallmeier, K. H. Dallmeier, K.H. Dallmeier, Kai Dallmeier, Martial Seveno, Osbourne Quaye

159

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Rega Institute for Medical Research KU Leuven Global Virus Network Inserm Ghent University

About

Kai Dallmeier is an author at Rega Institute for Medical Research specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.8K
2	Epidemiology	3	3	107
3	Natural Sciences	2	2	55
4	Public Health	2	2	52
5	Biochemistry	1	1	63

Kai Dallmeier

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches Martin Guilliams, Johnny Bonnardel, Birthe Haest, Cell	2022	854
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug Eloise Mastrangelo, Margherita Pezzullo, Tine De Burghgraeve, Journal of Antimicrobial Chemotherapy	2012	419
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Nature Communications	2020	287
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries, Proceedings of the National Academy of Sciences Antiviral CompoundEmerging Infectious DiseasesLacks ActivityHigh DoseMedicine	2020	281
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 Jim Baggen, Leentje Persoons, Els Vanstreels, Nature Genetics Proviral Host FactorImmunologyVirologyGene EditingGenome Editing	2021	232
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral Leen Delang, Nidya Alexandra Segura Guerrero, Ali Taş, Journal of Antimicrobial Chemotherapy	2014	225
A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant Recipients Yannick Debing, A. Gisa, Kai Dallmeier, Gastroenterology Viral ReplicationTransplantationHepatologyRibavirin Treatment FailureViral Hepatitis	2014	201
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma, Nature	2020	184
A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction Suzanne J. F. Kaptein, Olivia Goethals, Dominik Kiemel, Nature Ns3–ns4b InteractionImmunologyAntiviral Drug DevelopmentVirologyAntiviral Drug	2021	181
Ribavirin Inhibits <i>In Vitro</i> Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon Yannick Debing, Suzanne U. Emerson, Yijin Wang, Antimicrobial Agents and Chemotherapy	2013	147

Page 1